Shares of Biocept, Inc. (NASDAQ:BIOC) Advance After Release of Study Results

Shares of Biocept, Inc. (NASDAQ:BIOC) Advance After Release of Study Results

Molecular diagnostics company, Biocept, Inc. (NASDAQ:BIOC), announced that clinical results from a study demonstrated up to 90% concordance. SAN DIEGO, Oct. 20, 2016 /PRNewswire/ — Biocept, Inc. (BIOC), a molecular diagnostics company commercializing and developing proprietary liquid biopsy tests that provide information to physicians to improve cancer treatment, announces that clinical results from a study evaluating 40 patients with advanced non-small cell lung cancer (NSCLC) demonstrated up to 90% concordance […]

Read More ˃